drugset / Trial / NCT01326338

Nitazoxanide for the Treatment of Prolonged Diarrhea in Children

NCT01326338 ↗

Phase 3 Completed 100 enrolled Romark Laboratories L.C.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study was to determine the efficacy of nitazoxanide suspension compared to placebo in treating prolonged diarrhea in children.

Timeline

Start
2005-03
Primary completion
2006-05
Completion
2006-05

Outcome

Met primary endpoint

paper 23 hours (IQR 4-48 hours) vs 103.5 hours (IQR 63->168 hours) for placebo (p<0.001). PMID 22301075 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitazoxanide Other / unclassified 100 mg Oral
Subject Nitazoxanide Other / unclassified 200 mg Oral

Indications